Skip to main content

Advertisement

SpringerLink
Log in

Apathy and associated factors in Mexican patients with Parkinson’s disease

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Apathy is one of the most common behavioral disturbances in Parkinson’s disease (PD) with a reported prevalence of 17–51 %. Apathy has been associated with depression, cognitive deficits, and poor quality of life. The objective of this study was to determine the prevalence of apathy in Mexican subjects with PD and its correlation with clinical and demographic characteristics. A cross-sectional, descriptive, and analytic study was carried out. Consecutive subjects with PD attending the National Institute of Neurology and Neurosurgery in Mexico City were included. Demographic and other relevant clinical data were collected. The Apathy Scale was applied to all subjects. A cut-off score of ≥14 was used. A total of 241 non-demented patients (52.7 % male) were included. Apathy was found in 43 % of subjects. Lower body mass index, older age of PD onset, cognitive decline and disease severity were all related to apathy. The use of dopamine agonists or rasagiline was more common in patients with low apathy scores. Our results show that the prevalence of apathy in Mexican subjects with PD is similar to other reports.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aarsland D, Larsen JP, Lim NG, Janvin C, Karlsen K, Tandberg E, Cummings JL (1999) Range of neuropsychiatric disturbances in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 67:492–496

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, Weintraub D, Sampaio C, Poewe W, Rascol O, Stebbins GT, Goetz CG (2008) Apathy and anhedonia rating scales in Parkinson’s disease: critique and recommendations. Mov Disord 23:2004–2014

    Article  PubMed  Google Scholar 

  3. Marin RS (1991) Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 3:243–254

    CAS  PubMed  Google Scholar 

  4. Marin RS (1990) Differential diagnosis and classification of apathy. Am J Psychiatry 147:22–30

    CAS  PubMed  Google Scholar 

  5. Pedersen KF, Alves G, Aarsland D, Larsen JP (2009) Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study. J Neurol Neurosurg Psychiatry 80:1279–1282

    Article  CAS  PubMed  Google Scholar 

  6. Serrano-Dueñas MM-MP, Merchan T, Bravo R, Serrano M (2013) Properties of the Apathy Scale (AS) for use on Parkinson’s patients. Adv Parkinson’s Dis 2:53–57

    Article  Google Scholar 

  7. Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:745–752

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25:2649–2653

    Article  PubMed  Google Scholar 

  9. Hoehn MM (1987) Parkinson’s disease: progression and mortality. Adv Neurol 45:457–461

    CAS  PubMed  Google Scholar 

  10. Martinez-Martin P, Rodriguez-Blazquez C, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martinez-Castrillo JC, Mendoza-Rodriguez A, Moore HP, Rodriguez-Violante M, Singer C, Tilley BC, Huang J, Stebbins GT, Goetz CG (2013) Expanded and independent validation of the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS). J Neurol 260:228–236

    Article  PubMed  Google Scholar 

  11. Oh JY, Kim YS, Choi BH, Sohn EH, Lee AY (2009) Relationship between clinical phenotypes and cognitive impairment in Parkinson’s disease (PD). Arch Gerontol Geriatr 49:351–354

    Article  PubMed  Google Scholar 

  12. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I (1990) Variable expression of Parkinson’s disease: a base-line analysis of the DATATOP cohort. The Parkinson study group. Neurology 40:1529–1534

    Article  CAS  PubMed  Google Scholar 

  13. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699

    Article  PubMed  Google Scholar 

  14. Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG (1992) Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 4:134–139

    CAS  PubMed  Google Scholar 

  15. Volicer L, Frijters DH, van der Steen JT (2013) Apathy and weight loss in nursing home residents: longitudinal study. J Am Med Dir Assoc 14:417–420

    Article  PubMed  Google Scholar 

  16. Pedersen KF, Larsen JP, Alves G, Aarsland D (2009) Prevalence and clinical correlates of apathy in Parkinson’s disease: a community-based study. Parkinsonism Relat Disord 15:295–299

    Article  PubMed  Google Scholar 

  17. Czernecki V, Pillon B, Houeto JL, Pochon JB, Levy R, Dubois B (2002) Motivation, reward, and Parkinson’s disease: influence of dopatherapy. Neuropsychologia 40:2257–2267

    Article  CAS  PubMed  Google Scholar 

  18. Leentjens AF, Koester J, Fruh B, Shephard DT, Barone P, Houben JJ (2009) The effect of pramipexole on mood and motivational symptoms in Parkinson’s disease: a meta-analysis of placebo-controlled studies. Clin Ther 31:89–98

    Article  CAS  PubMed  Google Scholar 

  19. Skorvanek M, Rosenberger J, Gdovinova Z, Nagyova I, Saeedian RG, Groothoff JW, Dijk JP (2013) Apathy in elderly nondemented patients with Parkinson’s disease: clinical determinants and relationship to quality of life. J Geriatr Psychiatry Neurol 26:237–243

    Article  PubMed  Google Scholar 

  20. Le Jeune F, Drapier D, Bourguignon A, Peron J, Mesbah H, Drapier S, Sauleau P, Haegelen C, Travers D, Garin E, Malbert CH, Millet B, Verin M (2009) Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. Neurology 73:1746–1751

    Article  PubMed  Google Scholar 

  21. Czernecki V, Schupbach M, Yaici S, Levy R, Bardinet E, Yelnik J, Dubois B, Agid Y (2008) Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom. Mov Disord 23:964–969

    Article  PubMed  Google Scholar 

  22. Ray Chaudhuri K, Martinez-Martin P, Antonini A, Brown RG, Friedman JH, Onofrj M, Surmann E, Ghys L, Trenkwalder C (2013) Rotigotine and specific non-motor symptoms of Parkinson’s disease: post hoc analysis of RECOVER. Parkinsonism Relat Disord 19:660–665

    Article  CAS  PubMed  Google Scholar 

  23. Fernandez HH, Chen JJ (2007) Monoamine oxidase-B inhibition in the treatment of Parkinson’s disease. Pharmacotherapy 27:174S–185S

    Article  CAS  PubMed  Google Scholar 

  24. Isella V, Melzi P, Grimaldi M, Iurlaro S, Piolti R, Ferrarese C, Frattola L, Appollonio I (2002) Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson’s disease. Mov Disord 17:366–371

    Article  PubMed  Google Scholar 

  25. Zgaljardic DJ, Borod JC, Foldi NS, Rocco M, Mattis PJ, Gordon MF, Feigin AS, Eidelberg D (2007) Relationship between self-reported apathy and executive dysfunction in nondemented patients with Parkinson disease. Cogn Behav Neurol 20:184–192

    Article  PubMed  Google Scholar 

  26. Cubo E, Benito-Leon J, Coronell C, Armesto D (2012) Clinical correlates of apathy in patients recently diagnosed with Parkinson’s disease: the ANIMO study. Neuroepidemiology 38:48–55

    Article  PubMed Central  PubMed  Google Scholar 

  27. Starkstein SE (2012) Apathy in Parkinson’s disease: diagnostic and etiological dilemmas. Mov Disord 27:174–178

    Article  PubMed  Google Scholar 

  28. Kirsch-Darrow L, Marsiske M, Okun MS, Bauer R, Bowers D (2011) Apathy and depression: separate factors in Parkinson’s disease. J Int Neuropsychol Soc 17:1058–1066

    Article  PubMed Central  PubMed  Google Scholar 

  29. Robert G, Le Jeune F, Lozachmeur C, Drapier S, Dondaine T, Peron J, Travers D, Sauleau P, Millet B, Verin M, Drapier D (2012) Apathy in patients with Parkinson disease without dementia or depression: a PET study. Neurology 79:1155–1160

    Article  CAS  PubMed  Google Scholar 

  30. Zahodne LB, Bernal-Pacheco O, Bowers D, Ward H, Oyama G, Limotai N, Velez-Lago F, Rodriguez RL, Malaty I, McFarland NR, Okun MS (2012) Are selective serotonin reuptake inhibitors associated with greater apathy in Parkinson’s disease? J Neuropsychiatry Clin Neurosci 24:326–330

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Sansone RA, Sansone LA (2010) SSRI-induced indifference. Psychiatry (Edgmont) 7:14–18

    Google Scholar 

  32. Gallagher DA, Goetz CG, Stebbins G, Lees AJ, Schrag A (2012) Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson’s disease. Mov Disord 27:79–83

    Article  PubMed  Google Scholar 

  33. Martinez-Martin P, Chaudhuri KR, Rojo-Abuin JM, Rodriguez-Blazquez C, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martinez-Castrillo JC, Mendoza-Rodriguez A, Moore HP, Rodriguez-Violante M, Singer C, Tilley BC, Huang J, Stebbins GT, Goetz CG (2013) Assessing the non-motor symptoms of Parkinson’s disease: MDS-UPDRS and NMS Scale. Eur J Neurol. doi:10.111/ene.12165

  34. Harris E, McNamara P, Durso R (2013) Apathy in patients with Parkinson disease as a function of side of onset. J Geriatr Psychiatry Neurol 26:95–104

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have no conflict of interest to report.

Author information

Authors and Affiliations

  1. Clinical Laboratory of Neurodegenerative Diseases, National Institute of Neurology and Neurosurgery, Insurgentes Sur #3877 Col. La Fama, 14269, Mexico City, Mexico

    Mayela Rodríguez-Violante, Paulina González-Latapi, Amin Cervantes-Arriaga, Daniel Martínez-Ramírez & Azyadeh Camacho-Ordoñez

  2. Movement Disorders Clinic, National Institute of Neurology and Neurosurgery, Mexico City, Mexico

    Mayela Rodríguez-Violante, Daniel Martínez-Ramírez & Salvador Velázquez-Osuna

Authors
  1. Mayela Rodríguez-Violante
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paulina González-Latapi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amin Cervantes-Arriaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniel Martínez-Ramírez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Salvador Velázquez-Osuna
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Azyadeh Camacho-Ordoñez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mayela Rodríguez-Violante.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rodríguez-Violante, M., González-Latapi, P., Cervantes-Arriaga, A. et al. Apathy and associated factors in Mexican patients with Parkinson’s disease. Neurol Sci 35, 729–734 (2014). https://doi.org/10.1007/s10072-013-1591-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-013-1591-6

Keywords

Search

Navigation